Effects of subminimal inhibitory concentrations of antibiotics in experimental infections

Insights

Sub-minimal inhibitory concentrations (sub-MICs) of antibiotics showed varied antibacterial effects. While some antibiotics at sub-MICs aided survival in certain gram-negative infections, others were ineffective or even detrimental.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antibiotic efficacy is typically assessed at or above minimal inhibitory concentrations (MICs).
  • The impact of sub-MIC antibiotic exposure on bacterial pathogens and host outcomes is less understood.
  • Sub-MIC antibiotic effects can include alterations in bacterial morphology and virulence.

Purpose of the Study:

  • To investigate the antibacterial effects of sub-MIC antibiotic concentrations in animal models.
  • To evaluate the impact of sub-MIC antibiotic treatment on bacterial growth and host survival.
  • To compare the efficacy of different antibiotics at sub-MIC levels against various bacterial infections.

Main Methods:

  • Two animal models were utilized: mice and rabbits.
  • Antibiotics tested included cephalosporins (CGP 9000, cephalexin, cephaloridine), ampicillin, and gentamicin.
  • Sub-MICs were administered orally or intravenously, with drug concentrations measured relative to the MIC.

Main Results:

  • In mice, oral cephalosporins at sub-MICs were effective against some gram-negative infections but not gram-positive ones.
  • In rabbits, sub-MIC beta-lactam antibiotics induced bacterial filamentation, and gentamicin caused enlargement of Proteus mirabilis, Escherichia coli, and Salmonella typhimurium.
  • Sub-MIC treatment prolonged survival in E. coli and P. mirabilis infections but shortened survival in S. typhimurium infections.

Conclusions:

  • Sub-MIC antibiotic concentrations can exhibit complex and sometimes paradoxical effects on bacterial infections.
  • The outcome of sub-MIC antibiotic treatment is dependent on the specific antibiotic, bacterial species, and infection model.
  • Further research is needed to fully elucidate the clinical implications of sub-MIC antibiotic exposure.

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...